The effect of pH, buffer capacity and ionic strength on quetiapine fumarate release from matrix tablets prepared using two different polymeric blends

References

• Berthelsen R, Sjögren E, Jacobsen J, et al. Combining in vitro and in silico methods for better prediction of surfactant effects on the absorption of poorly water soluble drugs—a fenofibrate case example. Int J Pharm. 2014;473:356–365.
   PubMed Web of Science ®Google Scholar
• Lehto P, Kortejärvi H, Liimatainen A, et al. Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs. Eur J Pharm Biopharm. 2011;78:531–538.
   PubMed Web of Science ®Google Scholar
• Pawar HA, Joshi PR. Development and validation of a discriminating in vitro dissolution method for oral formulations containing satranidazole. Int J Spectr. 2014;2014:1–7.
   Google Scholar
• Sheng JJ, McNanara DP, Amidon GL. Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers. Mol Pharm. 2009;6:29–39.
   PubMed Web of Science ®Google Scholar
• Sheng JJ, Kasim NA, Chandrasekharan R, et al. Solubilization and dissolution of insoluble weak acid, ketoprofen: effects of pH combined with surfactant. Eur J Pharm Sci. 2006;29:306–314.
   PubMed Web of Science ®Google Scholar
• Tsume Y, Mudie DM, Langguth P, et al. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Eur J Pharm Sci. 2014;57:152–163.
   PubMed Web of Science ®Google Scholar
• Bonferoni MC, Rossi S, Tamayo M, et al. On the employment of λ-carrageenan in a matrix system. I. Sensitivity to dissolution medium and comparison with Na carboxymethylcellulose and xanthan gum. J Control Release. 1993;26:119–127.
   Web of Science ®Google Scholar
• Gil EC, Colarte AI, Bataille B, et al. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride. Int J Pharm. 2006;317:32–39.
   PubMed Web of Science ®Google Scholar
• Hardy IJ, Windberg-Baarup A, Neri C, et al. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone. Int J Pharm. 2007;337:246–253.
   PubMed Web of Science ®Google Scholar
• Hiremath PS, Saha RN. Oral matrix tablet formulations for concomitant controlled release of anti-tubercular drugs: design and in vitro evaluations. Int J Pharm. 2008;362:118–125.
   PubMed Web of Science ®Google Scholar
• Jamzad S, Fassihi R. Development of a controlled release low dose class II drug-Glipizide. Int J Pharm. 2006;312:24–32.
   PubMed Web of Science ®Google Scholar
• Li L, Wang LL, Li JF, et al. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release. Int J Pharm. 2014;476:253–265.
   PubMed Web of Science ®Google Scholar
• Kulinowski P, Woyna-Orlewicz K, Rappen GM, et al. An understanding of modified release matrix tablets behavior during drug dissolution as the key for prediction of pharmaceutical product performance – case study of multimodal characterization of quetiapine fumarate tablets. Int J Pharm. 2015;484:235–245.
   PubMed Web of Science ®Google Scholar
• Hamed R, Awadallah A, Sunoqrot S, et al. pH-dependent solubility and dissolution behavior of carvedilol—Case example of a weakly basic BCS class II drug. AAPS PharmSciTech. 2016;17:418–446.
   PubMed Web of Science ®Google Scholar
• Bhattachar SN, Risley DS, Werawatganone P, et al. Weak bases and formation of a less soluble lauryl sulfate salt/complex in sodium lauryl sulfate (SLS) containing media. Int J Pharm. 2011;412:95–98.
   PubMed Web of Science ®Google Scholar
• Parojcić J, Ethurić Z, Jovanović M, et al. Influence of dissolution media composition on drug release and in-vitro/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers. J Pharm Pharmacol. 2004;56:735–741.
   PubMed Web of Science ®Google Scholar
• Xie X, Cardot J-M, Garrait G, et al. Micelle dynamic simulation and physicochemical characterization of biorelevant media to reflect gastrointestinal environment in fasted and fed states. Eur J Pharm Biopharm. 2014;88:565–573.
   PubMed Web of Science ®Google Scholar
• Asare-Addo K, Conway BR, Larhrib H, et al. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices. Colloid Surface B. 2013;111:384–391.
   PubMed Web of Science ®Google Scholar
• Asare-Addo K, Levina M, Rajabi-Siahboomi AR, et al. Effect of ionic strength and pH of dissolution media on theophylline release from hypromellose matrix tablets—Apparatus USP III, simulated fasted and fed conditions. Carbohydr Polym. 2011;86:85–93.
   Web of Science ®Google Scholar
• Reppas C, Friedel H-D, Barker AR, et al. Biorelevant in vitro performance testing of orally administered dosage forms—Workshop report. Pharm Res. 2014;31:1867–1876.
   PubMed Web of Science ®Google Scholar
• Goldstein JM. Quetiapine fumarate (Seroquel): a new atypical antipsychotic. Drugs Today. 1999;35:193–210.
   PubMed Web of Science ®Google Scholar
• Garbacz G, Kandzi A, Koziolek M, et al. Release characteristics of quetiapine fumarate extended release tablets under biorelevant stress test conditions. AAPS Pharm Sci Tech. 2014;15:230–236.
   PubMed Web of Science ®Google Scholar
• Hamed R, Al-Samydai A, Al Baraghthi T, et al. Influence of HPMC K100LV and Compritol® HD5 ATO on drug release and rheological behavior of HPMC K4M matrix tablets. J Pharm Innov. 2017;2:62–75.
   Web of Science ®Google Scholar
• US FDA dissolution methods for quetiapine fumarate extended release and conventional tablets. [cited 2015 Nov 12]. Available from: http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp_SearchResults_Dissolutions.cfm
   Google Scholar
• Vertzoni M, Dressman J, Butler J, et al. Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. Eur J Pharm Biopharm. 2005;60:413–417.
   PubMed Web of Science ®Google Scholar
• Jantratid E, Janssen N, Reppas C, et al. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res. 2008;25:1663–1676.
   PubMed Web of Science ®Google Scholar
• Klein S, Wempe MF, Zoeller T, et al. Improving glyburide solubility and dissolution by complexation with hydroxybutenyl-beta-cyclodextrin. J Pharm Pharmacol. 2009;61:23–30.
   PubMed Web of Science ®Google Scholar
• Sigma-Aldrich. Buffer Reference Center. [Internet]. [cited 2016 Jan 30]. Available from: http://www.sigmaaldrich.com/life-science/core-bioreagents/biological-buffers/learning-center/buffer-reference-center.html - NA2HPO4
   Google Scholar
• Dressman JB, Amidon GL, Reppas C, et al. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res. 1998;15:11–22.
   PubMed Web of Science ®Google Scholar
• Klein S, Rudolph M, Dressman J. Drug release characteristics of different mesalazine products using USP apparatus 3 to simulate passage through the GI tract. Dissolut Technol. 2002;9:6–12.
   Google Scholar
• Solon K, Flores-Alsina X, Mbarnba CK, et al. Effects of ionic strength and ion pairing on (plant-wide) modelling of anaerobic digestion. Water Res. 2015;70:235–245.
   PubMed Web of Science ®Google Scholar
• Arndt M, Chokshi H, Tang K, et al. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state. Eur J Pharm Biopharm. 2013;84:633–641.
   PubMed Web of Science ®Google Scholar
• Jamzad S, Fassihi R. Role of surfactant and pH on dissolution properties of fenofibrate and glipizide-a technical note. AAPS PharmSciTech. 2006;7:E33.
   PubMed Web of Science ®Google Scholar
• Buffered and isotonic solutions. In: Sinko PJ, editor. Martin’s physical pharmacy and pharmaceutical sciences. 6th ed. Philadelphia (PA): Lippincott Williams and Wilkins; 2011; p. 164–182.
   Google Scholar
• SUPAC-MR: modified release solid oral dosage forms, guidance for Industry, 1997.
   Google Scholar
• Costa P, Manuel J, Lobo S. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123–133.
   PubMed Web of Science ®Google Scholar
• Tukaram BN, Rajagopalan IV, Shartchandra PSI. The effects of lactose, microcrystalline cellulose and dicalcium phosphate on swelling and erosion of compressed HPMC matrix tablets: texture analyzer. Iran J Pharm Res. 2010;9:349–358.
   PubMed Web of Science ®Google Scholar
• Reynolds TD, Dasbach TP. A study of polymers blending and polymer erosion of different viscosity grades of HPMC for hydrophilic matrix tablets. Paper presented on the AAPS conference 1999; New Orleans, LA.
   Google Scholar
• Pygall SR, Kujawinski S, Timmins P, et al. Mechanisms of drug release in citrate buffered HPMC matrices. Int J Pharm. 2009;370:110–20.
   PubMed Web of Science ®Google Scholar
• Garrido G, Ràfols C, Bosch E. Acidity constants in methanol/water mixtures of polycarboxylic acids used in drug salt preparations: potentiometric determination of aqueous pKa values of quetiapine formulated as hemifumarate. Eur J Pharm Sci. 2006;28:118–127.
   PubMed Web of Science ®Google Scholar
• Shoghi E, Fuguet E, Bosch E, et al. Solubility-pH profiles of some acidic, basic and amphoteric drugs. Eur J Pharm Sci. 2013;48:291–300.
   PubMed Web of Science ®Google Scholar
• Völgyi G, Baka E, Box KJ, et al. Study of pH-dependent solubility of organic bases. Revisit of Henderson-Hasselbalch relationship. Anal Chim Acta. 2010;673:40–46.
   PubMed Web of Science ®Google Scholar
• Ozturk SS, Palsson BO, Dressman JB. Dissolution of ionizable drugs in buffered and unbuffered solutions. Pharm Res. 1988;5:272–282.
   PubMed Web of Science ®Google Scholar
• Willey JD. The effect of ionic strength on the solubility of an electrolyte. J Chem Educ. 2004;81:1644.
   Web of Science ®Google Scholar
• Remington R, Beringer P. Ionic solutions and electrolyte equilibria. In: Troy DB, Beringer P, editors. Remington: the science and practice of pharmacy. 21st ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2006; p. 231–250.
   Google Scholar
• Asare-Addo K, Kaialy W, Levina M, et al. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices–the use of the USP III apparatus. Colloid Surf B. 2013;104:54–60.
   PubMed Web of Science ®Google Scholar
• Alderman D. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int J Pharm Technol Prod Manufact. 1984;5:1–9.
   Google Scholar
• Ford JL, Rubinstein MH, Changela A, et al. Influence of pH on the dissolution of promethazine hydrochloride from hydroxypropylmethylcellulose controlled release tablets. J Pharm Pharmacol.1985;37:115P.
   Google Scholar
• Ford JL. Design and evaluation of hydroxypropyl methylcellulose matrix tablets for oral controlled release: a historical perspective. In: Timmins P, Pygall SR, Melia CD, editors. Vol.16, Hydrophilic matrix tablets for oral controlled release. AAPS advances in the pharmaceutical sciences series. New York (NY): Springer; 2014; p. 17–51.
   Google Scholar
• Remington R, Beringer P. Colloidal dispersions. In: Troy DB, Beringer P, editors. Remington: the science and practice of pharmacy. 21st ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2006; p. 293–319.
   Google Scholar
• A formulation development perspective on critical interactions affecting the performance of hydrophilic matrix tablets. In: Timmins P, Pygall SR, Melia CD, editors. Hydrophilic matrix tablets for oral controlled release. 1st ed. New York (NY): Springer-Verlag; 2014; p. 143–165.
   Google Scholar
• Asare-Addo K, Levina M, Rajabi-Siahboomi AR, et al. Study of dissolution hydrodynamic conditions versus drug release from hypromellose matrices: the influence of agitation sequence. Colloid Surf B. 2010;81:452–460.
   PubMed Web of Science ®Google Scholar
• Kavanagh N, Corrigan OI. Swelling and erosion properties of hydroxypropylmethylcellulose (Hypromellose) matrices—influence of agitation rate and dissolution medium composition. Int J Pharm. 2004;279:141–152.
   PubMed Web of Science ®Google Scholar
• Fini A, Cavallari C, Ospitali F, et al. Theophylline-loaded compritol microspheres prepared by ultrasound-assisted atomization. J Pharm Sci. 2011;100:743–757.
   PubMed Web of Science ®Google Scholar
• NDiaye A, Jannin V, Berard V, et al. Comparative study of the lubricant performance of Compritol (R) HD5 ATO and Compritol (R) 888 ATO: effect of polyethylene glycol behenate on lubricant capacity. Int J Pharm. 2003;254:263–269.
   PubMed Web of Science ®Google Scholar
• Ustundag-Okur N, Gökçe EH, Bozbiyik DI, et al. Preparation and in vitro–in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. Eur J Pharm Sci. 2014;63:204–215.
   PubMed Web of Science ®Google Scholar
• Aksu B, Yurdasiper A, Ege M, et al. Development and comparative evaluation of extended release indomethacin capsules. Afr J Pharm Pharmacol. 2013;7:2201–2209.
   Google Scholar
• Barakat NS, Elbagory IM, Almurshedi AS. Controlled-release carbamazepine granules and tablets comprising lipophilic and hydrophilic matrix components. AAPS Pharm Sci Tech. 2008;9:1054–1062.
   PubMed Web of Science ®Google Scholar
• Ansari M, Kazemipour M, Talebnia J. The Development and validation of a dissolution method for clomipramine solid dosage forms. Dissolut Technol. 2004;11:16–24.
   Google Scholar
• Anand O, Lawrence XY, Conner DP, et al. Dissolution testing for generic drugs: an FDA perspective. AAPS J. 2011;3:328–335.
   Web of Science ®Google Scholar
• Bergström CAS, Holm R, Jorgensen SA, et al. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs. Eur J Pharm Sci. 2014;57:173–199.
   PubMed Web of Science ®Google Scholar
• Garbacz G, Kolodziej B, Koziolek M, et al. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds. Eur J Pharm Sci. 2014;51:224–231.
   PubMed Web of Science ®Google Scholar
• Kalantzi L, Goumas K, Kalioras V, et al. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm Res. 2006;23:165–176.
   PubMed Web of Science ®Google Scholar
• Lindahl A, Ungell AL, Knutson L, et al. Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm Res. 1997;14:497–502.
   PubMed Web of Science ®Google Scholar
• Johnson JL, Holinej J, Williams MD. Influence of ionic-strength on matrix integrity and drug release from hydroxypropyl cellulose compacts. Int J Pharm.1993;90:151–159.
   Web of Science ®Google Scholar